Biolinx Africa Hero
Background Pattern

CONNECTING IDEAS, PEOPLE AND POSSIBILITIES FOR A HEALTHIER TOMORROW

Genomics & Bioinformatics Platform

We provide healthcare providers, researchers, and industry with next-generation sequencing (NGS) and bioinformatics services for genomics, transcriptomics, proteomics, metabolomics, and microbiome studies — advancing precision medicine and biopharma R&D.

Clinical Research Platform

We partner with healthcare providers to establish and operate clinical trial sites (SMOs). In collaboration with regulators and sponsors, we promote equity in translational research while delivering high-quality clinical trial data aligned with both local ethos and global standards.

Health Data & AI/ML Platform (Viwingu)

We empower researchers and innovators with tools to analyze health data, enhance diagnostics, and design smarter, cost-effective clinical trials using AI and machine learning.

Background Pattern

About Biolinx Africa

Biolinx Africa is a pioneering biotech venture studio and innovation catalyst dedicated to transforming Africa’s health security through homegrown solutions. Born from Villgro Africa, we focus on building globally competitive biotech and medtech startups while strengthening Africa’s healthcare innovation ecosystem.

Our Vision

To establish a vibrant, globally competitive health research & innovation ecosystem that underpins Africa's health security and resilience.

Our Mission

Our mission is to invest in African-led innovations and bridge the gap between local ingenuity and global resources — ensuring breakthroughs in genomics, proteomics and precision medicine are both accessible and relevant to African populations

Background Pattern

Our Operational Model

We believe that the future of Africa's healthcare lies in locally driven innovation — supported by world-class infrastructure, global partnerships and access to cutting-edge tools like genomics and AI/ML, hence our unique venture studio and ecosystem building operational model.

Venture Building

For venture building, our Bioxcelerator Venture Studio model scouts for homegrown ideas and talent to co-create health solutions for local and global markets by building an integrated pipeline for co-creation from ideation to investment-ready ventures.

Venture Studio

To innovators and investors, we identify and develop early-stage ideas into investable biotech startups, leveraging Africa’s genetic diversity for discovery, and world-class infrastructure for commercialization.

Biolinx Africa workflow and process overview

To global-north health solution developers we provide best-of-class go-to-market support that includes:

  • Building and validating business models for market entry and scale
  • Navigating Africa's regulatory landscape
  • Establishing strategic partnerships with local manufacturers and distributors
Background Pattern

Ecosystem Building

For ecosystem building, we are addressing critical gaps in Africa's health innovation landscape — from poor access to health data, to underrepresentation in clinical trials and genomic databases, to lack of market entry support for global health solutions — by building an integrated platform of service providers, namely:

Genomics & Bioinformatics Platform Nextgen Molecular Lab & TAGCC

To healthcare providers, researchers and industry, we provide next generation sequencing (NGS) and bioinformatics services tailored for genomics, transcriptomics, proteomics, metabolomics and microbiome for precision medicine and biopharma R&D services.

Clinical Research Platform Clinical Research

We partner with healthcare providers to establish capacity and operate as clinical trial sites (SMOs). We also partner with regulators and trial sponsors to promote equity in translational research by facilitating the production of high-quality clinical trial data in Africa that is aligned with local ethos while meeting global standards.

Genomics/Health Data Repository & AI/ML Platform Viwingu

We empower researchers, innovators with advanced tools to analyze health data, improve diagnostics, and design smarter and cost-effective clinical trials.

Background Pattern

Our Portfolio

Building on the East Africa Biosciences Studio, the Bioxcelerator program is developing a novel test for prostate cancer diagnosis whose patent registration is ongoing and seeking partnerships with industry for the product commercialization.

Prostate Cancer Diagnostic Test

Prostate Cancer Diagnostic Test

A novel diagnostic test developed under the Bioxcelerator program. Patent registration is ongoing, with partnerships being sought for commercialization.

Learn More →
East Africa Biosciences Studio

East Africa Biosciences Studio

A pilot program focused on cancer innovation, laying the foundation for future biotech venture building across Africa.

Learn More →

Our Leadership Team

Biolinx Africa's leadership team brings together over 85 years of experience in health research, innovation, entrepreneurship, and early-stage investment across Africa and Europe.

Dr. Robert Karanja

Dr. Robert Karanja

Executive Director & Bioxcelerator Lead

Dr. Lutchmee Nobaub

Dr. Lutchmee Nobaub

CRO Lead

Mr. Michael Karaimu

Mr. Michael Karaimu

Investment Lead

Dr. Fiona Okonjo

Dr. Fiona Okonjo

UK Country Director

Our Advisory Board

Our advisory board consists of globally recognised leaders with expertise in R&D, commercialisation, and venture capital in health and life sciences across Africa and Europe.

Dr. Joerg Rippmann

Dr. Joerg Rippmann

Director Pharmacology, Boehringer Ingelheim

Ms. Carol Banks

Ms. Carol Banks

Founder and CEO Innovare Health Collective

Dr. Jeremmy Okonjo

Dr. Jeremmy Okonjo

Assistant Professor of International Economic Law at University of Warwick

Dr. Damaris Matoke-Muhia

Dr. Damaris Matoke-Muhia

Deputy Director, Biotechnology Programme, KEMRI

Prof. Mehdi Tavakoli

Prof. Mehdi Tavakoli

Innovate UK

Sewu-Steve Tawia

Sewu-Steve Tawia

Managing Partner, Chief Investment Officer, Jaza Rift Ventures

Dr. Maricianah Onono

Dr. Maricianah Onono

Senior Principal Clinical Research Scientist, KEMRI